Zofran (Ondasetron): Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Category:Drug]] | [[Category:Drug]] | ||
[[Category:Antiemetics]] | [[Category:Antiemetics]] | ||
[[Category:5-HT3]] | [[Category:5-HT3]] | ||
{{Infobox drug|Drug_name=Zofran|IUPAC_name=(RS)-1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one|Image=Zofran.png|Caption=Zofran 4 mg tablet|Type=Antiemetic|Used_for=Prevention of nausea and vomiting|ATC_code=A04AA01|Legal_status=Prescription only|Routes_of_administration=Oral, intravenous, intramuscular|Bioavailability=58% (Oral)|Protein_bound=70-76%|Metabolism=Liver (CYP2D6, CYP3A4)|Elimination_half-life=3-6 hours|Excretion=Kidney (60%), feces (40%)|CAS_number=99614-02-5|PubChem=43815|drug_name=FDASF|INN=ASDFADS|image=}} | |||
==Route of administration== | ==Route of administration== | ||